Mirae Asset Global Etfs Holdings Ltd. Halozyme Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 85,778 shares of HALO stock, worth $4.77 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,778
Previous 86,087
0.36%
Holding current value
$4.77 Million
Previous $4.12 Million
33.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HALO
# of Institutions
595Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$980 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$714 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$337 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$217 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$204 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.75B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...